Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
sunray3's Profile
Displaying 1-50 of 183 result(s).
CYDY CytoDyn Inc
09/06/2025 1:42:07 PM
Now that speaks volumes. Good doc, (4)
CYDY CytoDyn Inc
07/28/2025 7:32:47 PM
I'm sure you're right, there are go
CYDY CytoDyn Inc
07/28/2025 12:02:02 PM
If so (not doubting you) then not h (8)
CYDY CytoDyn Inc
07/28/2025 11:18:19 AM
Thanks for the update on Dr C's sta (7)
CYDY CytoDyn Inc
07/25/2025 2:10:19 PM
Can some kind soul who remembers th (1)
CYDY CytoDyn Inc
07/24/2025 1:58:43 PM
Well said. Free leronlimab! (2)
CYDY CytoDyn Inc
07/23/2025 1:12:31 PM
Oh, I'm sure as I suspect you are t (7)
CYDY CytoDyn Inc
07/23/2025 12:07:51 PM
Now mind you, I don't pretend to kn (3)
CYDY CytoDyn Inc
07/23/2025 11:11:08 AM
Definitely BS, you're right...the M (7)
CYDY CytoDyn Inc
07/22/2025 10:36:07 AM
Well, I must admit that's a compell (11)
CYDY CytoDyn Inc
07/22/2025 9:05:38 AM
Agree, and as you say the acquirer (11)
CYDY CytoDyn Inc
07/03/2025 8:50:48 AM
Ah, good point. Thanks, I agree.
CYDY CytoDyn Inc
07/03/2025 1:08:38 AM
The question for me is does that la (4)
CYDY CytoDyn Inc
06/30/2025 2:48:01 PM
The chart price action has been int (9)
CYDY CytoDyn Inc
06/30/2025 1:09:38 PM
The ORR for TAS-102 and bevacizumab (4)
CYDY CytoDyn Inc
06/27/2025 1:52:44 PM
As I understand it and I've checked (9)
CYDY CytoDyn Inc
06/25/2025 11:11:13 AM
And yet here the Gates foundation i
CYDY CytoDyn Inc
06/24/2025 11:37:56 AM
Syneos as a clinical operations par (5)
CYDY CytoDyn Inc
06/23/2025 7:40:36 PM
Maybe. I agree with you about the m (2)
CYDY CytoDyn Inc
06/23/2025 1:48:54 PM
As per our previous conversation, w (2)
CYDY CytoDyn Inc
06/23/2025 11:58:40 AM
Just looked into it further, that w (1)
CYDY CytoDyn Inc
06/23/2025 10:58:00 AM
No, I think he's just congratulatin (1)
CYDY CytoDyn Inc
06/22/2025 3:25:09 PM
Heavens, I don't recall accusing an (4)
CYDY CytoDyn Inc
06/21/2025 11:31:19 AM
And way cheaper, you can be sure.
CYDY CytoDyn Inc
06/19/2025 4:10:48 PM
I'm no cardiologist, but I think th (3)
CYDY CytoDyn Inc
06/19/2025 11:22:48 AM
Glad you asked, some sources were s (2)
CYDY CytoDyn Inc
06/19/2025 1:05:54 AM
Yes, Dr Welch has many millions of (6)
CYDY CytoDyn Inc
06/17/2025 6:51:40 PM
Here's the link to the chart from m (2)
CYDY CytoDyn Inc
06/17/2025 6:32:13 PM
I can understand your thoughtful ob (2)
CYDY CytoDyn Inc
06/17/2025 12:43:00 PM
Yes to the first, no to the second. (7)
CYDY CytoDyn Inc
06/16/2025 9:58:58 AM
Pretty much, except that the two Me (1)
CYDY CytoDyn Inc
06/16/2025 2:33:07 AM
And let's not forget the PD-L1 bloc (7)
CYDY CytoDyn Inc
06/11/2025 3:41:44 PM
Nice reply, thanks. I agree general (9)
CYDY CytoDyn Inc
06/10/2025 2:00:30 PM
OK mods, this is that last one, I p (5)
CYDY CytoDyn Inc
06/10/2025 1:07:07 PM
I asked ChatGPT to analyze the leve (8)
CYDY CytoDyn Inc
06/10/2025 11:18:18 AM
Yeah, I guess that would be my poin (3)
CYDY CytoDyn Inc
06/10/2025 10:50:09 AM
And regarding the regulatory treatm (3)
CYDY CytoDyn Inc
06/10/2025 10:11:00 AM
I did some further research utilizi (4)
CYDY CytoDyn Inc
06/08/2025 10:52:28 AM
I agree, actually, and there's no w (7)
CYDY CytoDyn Inc
05/27/2025 10:39:42 AM
Touche, KC, that was hilarious, poi (4)
CYDY CytoDyn Inc
05/27/2025 9:29:27 AM
I agree. I use ChatGPT for research (3)
CYDY CytoDyn Inc
05/26/2025 7:34:40 PM
Interesting thought! In athe same v (12)
CYDY CytoDyn Inc
05/22/2025 1:51:52 PM
I understand what you're saying and (2)
CYDY CytoDyn Inc
05/19/2025 11:52:08 AM
I'm with you there, Max (ViiV/GSK) (2)
CYDY CytoDyn Inc
05/19/2025 11:10:11 AM
And if they wanted, Merck could rea (2)
CYDY CytoDyn Inc
05/18/2025 4:57:45 PM
Not being contrary here, but I just (2)
CYDY CytoDyn Inc
05/18/2025 1:35:11 PM
That got me to thinking about Leron (5)
CYDY CytoDyn Inc
05/18/2025 1:26:38 PM
I hear you. Still, Max Detaillade i (7)
CYDY CytoDyn Inc
05/18/2025 12:56:46 PM
I got one of those letters, and fro (5)
CYDY CytoDyn Inc
05/16/2025 6:41:46 PM
I got the same, it was for the cash (5)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Lockheed Martin Pursues Class Action Lawsuit: Key Updates
  • Tronox Holdings plc Faces Lawsuit: Key Details for Investors
  • Levi & Korsinsky to Represent Investors in C3.ai, Inc. Class Action
  • Legal Action Highlights Concerns for Charter Communications Investors
  • Exploring the Growth of the Indoor 5G Market by 2034
  • Key Actions for PubMatic, Inc. Investors: Class Action Update
  • CleanCore Expands Its Dogecoin Treasury to 500 Million DOGE
  • Fly-E Group Inc. Faces Class Action Allegations from Shareholders
  • Investors of LifeMD, Inc. Encouraged to Seek Legal Help Now
  • Essential Update for Nutex Health Investors Amid Lawsuit
  • N3on and Iggy Azalea Elevate Online Gaming with MOTHERLAND
  • Toll Brothers Unveils Modern Community at Coldwater Ridge
  • EliTe Solar Celebrates 20 Years of Innovation with New Logo
  • AGNC Investment Corp. Announces Upcoming Preferred Dividends
  • Franchises as a Path to Success: What Every Investor Should Know
  • Healogics Welcomes New Chief Legal and Compliance Leader
  • AGNC Investment Corp. Announces New Monthly Dividend Details
  • Highway Holdings Limited Releases First Quarter Insights
  • Rent the Runway Inc. Achieves Impressive Growth This Quarter
  • AGNC Investment Corp. Announces New Preferred Stock Dividends
  • AGNC Investment Corp. Announces September Dividend Payment Details
  • XTI Aerospace Plans Expansion with Proposed Public Offering
  • Experience Unmatched Game Day Hospitality with Lions VIP Tailgate
  • Accuray's Upcoming Analyst Event: Exploring Adaptive Radiotherapy
  • Alonaw Business School Achieves Record Enrollment in AI Course
  • Brain Co. Unveils $30 Million Fundraising Amid AI Revolution
  • Farmer Brothers Coffee Sees Positive Growth in Fiscal 2025
  • Significant Merger Completion of Aker Horizons ASA Subsidiaries
  • Team, Inc. Strengthens Financial Position with Preferred Stock Deal
  • Innovative Digital Textile Printing Solutions Unveiled
  • Aker Horizons ASA Completes Significant Merger with AKH HoldCo
  • Marimaca Copper Secures A$80 Million for Exploration and Growth
  • HeartSciences' Financial Growth and Innovative Avenues Explored
  • K. Hovnanian Enterprises Plans Major Offering of Senior Notes
  • Mueller Water Products to Showcase Innovations at Upcoming Conference
  • UWM Holdings Corp Experiences Price Increase Amid Economic Data
  • Next Technology Holding Inc. Implements Strategic Stock Split Changes
  • Unraveling the Intense Volatility of QMMM Holdings Shares
  • Zealand Pharma Enhances Shareholder Value through Capital Growth
  • Recludix Pharma's Pioneering Immunology Presentation Ahead
  • Precision Drilling's NCIB Renewal Aims to Enhance Share Value
  • Rent the Runway's Recent Financial Performance Overview
  • Investors of PubMatic, Inc. Encouraged to Join Class Action
  • Investing in Williams Companies: A 5-Year Growth Journey
  • Actuate Therapeutics Closes $17.25 Million Stock Offering
  • Kestra Medical Technologies Achieves Strong Q1 2026 Growth
  • Actuate Therapeutics Secures $17.25 Million in Stock Offering
  • Astec Industries to Engage Investors at Sidoti Conference Soon
  • Astec Industries to Engage at Sidoti Small Cap Conference
  • Monolithic Power Systems' Exciting Dividend Announcement
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site